Introducing Koala Prospector! Bringing Waterfall Enrichment to Reps

Learn More!
Biognosys

Biognosys

Biognosys is a leader in next-generation proteomics, dedicated to transforming life science by inventing and developing cutting-edge proteomics technology and solutions, and making them widely available for pharmaceutical and biotechnology researchers, and proteomics experts. The company offers a versatile portfolio of proprietary proteomics services, software, and kits, including the TrueDiscovery™, TrueTarget™, and TrueSignature™ platforms and flagship software Spectronaut™. These solutions provide a multi-dimensional view of protein expression, function, and structure in all biological species and sample types. Biognosys' unique, patented technologies utilize high-resolution mass spectrometry to quantify thousands of proteins across thousands of samples with industry-leading precision, depth, and throughput. Through advanced data analytics, Biognosys translates data into actionable insights for R&D and clinical research.

Last updated on

About Biognosys

Founded

2008

Estimated Revenue

$1M-$10M

Employees

51-250

Funding / Mkt. Cap

$9M

Category

Sector

Health Care

Industry Group

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Location

City

Schlieren

State

Zurich

Country

Switzerland
Biognosys

Biognosys

Find your buyer within Biognosys

Tech Stack (75)

search